Skip to main content

Table 2 Response rates and second line treatments with CT and RT

From: Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer

  Number of patients Percentage (%)
Number of PC received   
   1 2 4
   2 5 10
   3 20 39
   4 3 6
   5 3 6
   6 18 35
Response to PC   
   PR 23 45
   SD 9 18
   PD 16 31
   Not assessed 3 6
Second line CT 13  
   G ± Cis / C 10 78
   Other 3 23
Local RT 12  
   Stage IIIA 3 25
   Stage IIIB 5 42
   Stage IV 4 33
  1. CT: Chemotherapy; RT: Radiotherapy; P: Paclitaxel; C: Carboplatin; G: Gemcitabine; Cis: Cisplatin